Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Duroquinone is a synthetic organic compound belonging to the class of 1,4-benzoquinones in which all four hydrogens are substituted by methyl groups. It is a yellow powder and acts as an organic oxidant and antioxidant[2][3][7]. Duroquinone can undergo redox cycling in biological systems—being reduced by cellular reductases such as NAD(P)H quinone reductase (NQO1)—and can generate reactive oxygen species (ROS), leading to oxidative stress and potential damage to lipids, proteins, and DNA[8]. It has been studied for its role in redox regulation and detoxification processes within cells[1]. Duroquinone may also be formed as a degradation product from vitamin E acetate during vaping or pyrolysis[8][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on duroquinone.